MedTrace Logo

Sarcopaenia is a Useful Risk Stratification Tool for Surgeons to Prognosticate Splenic Abscess Patients

NCT03967041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2019-05-30

No results posted yet for this study

Summary

Sarcopaenia is associated with poor prognoses of in-hospital mortality in splenic abscess patients. Investigators recommend its use by surgeons in the ED to rapidly risk stratify and identify patients requiring urgent and aggressive intervention, to maximise patient outcomes and survival chances.

Conditions

Interventions

DIAGNOSTIC_TEST

radiological defined sarcopenia

Evaluation for sarcopaenia was performed via calculating psoas cross-sectional area at level of L3 and normalising for height

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-03-30
Completion
2019-04-15

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967041 on ClinicalTrials.gov